Literature DB >> 31568364

Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion, Number 788.

.   

Abstract

Barriers to access are one reason for inconsistent or nonuse of contraception. The requirement for a prescription can be an obstacle for some contraceptive users. Several studies have demonstrated that women are capable of using self-screening tools to determine their eligibility for hormonal contraceptive use. Pelvic and breast examinations, cervical cancer screening, and sexually transmitted infection screening are not required before initiating hormonal contraception and should not be used as reasons to deny access to hormonal contraception. Also, a plan to improve access to hormonal contraception should address cost issues. Pharmacist-provided contraception may be a necessary intermediate step to increase access to contraception, but over-the-counter access to hormonal contraception should be the ultimate goal. The American College of Obstetricians and Gynecologists supports over-the-counter access to hormonal contraception without age restrictions. This Committee Opinion has been updated to expand the focus of over-the-counter contraception to include oral contraceptive pills, vaginal rings, the contraceptive patch, and depot medroxyprogesterone acetate, to address the role of pharmacist-provided contraception, and to provide recommendations for individuals younger than 18 years.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31568364     DOI: 10.1097/AOG.0000000000003473

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study.

Authors:  Kristian Høj Reveles Jensen; Drummond E-Wen McCulloch; Anders Stevnhoved Olsen; Silvia Elisabetta Portis Bruzzone; Søren Vinther Larsen; Patrick MacDonald Fisher; Vibe Gedsoe Frokjaer
Journal:  Front Neurosci       Date:  2022-06-14       Impact factor: 5.152

2.  Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study.

Authors:  Alison Edelman; Agnes Hemon; Mitchell Creinin; Pascale Borensztein; Bruno Scherrer; Anna Glasier
Journal:  JMIR Res Protoc       Date:  2021-06-08

3.  Extended Access to Hormonal Contraception in Pharmacies: A Survey among Swiss Pharmacists.

Authors:  Tamara Yous; Samuel Allemann; Monika Lutters
Journal:  Pharmacy (Basel)       Date:  2020-11-10

4.  Declines in contraceptive visits in the United States during the COVID-19 pandemic.

Authors:  Maria W Steenland; Caroline K Geiger; Lucy Chen; Slawa Rokicki; Rebecca A Gourevitch; Anna D Sinaiko; Jessica L Cohen
Journal:  Contraception       Date:  2021-08-14       Impact factor: 3.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.